0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Ablation Market Size, Status and Forecast 2020-2026
Published Date: May 2020
|
Report Code: QYRE-Auto-16Y2588
Home | Market Reports | Health | Health Conditions | Cancer
Global Tumor Ablation Market Size Status and Forecast 2020 2026

Global Tumor Ablation Market Size, Status and Forecast 2020-2026

Code: QYRE-Auto-16Y2588
Report
May 2020
Pages:91
QYResearch
Description
Table of Content
Tables & Figures

Tumor Ablation Market Overview

The global Tumor Ablation market was valued at US$ 457.6 million in 2019 and is expected to reach US$ 878.5 million by the end of 2026, growing at a CAGR of 10.5% during 2021-2026.
 
Tumor Ablation is application in Liver Cancer, Lung Cancer, Kidney Cancer and Other cancers. The most proportion of Tumor Ablation is used in Lung Cancer, and the market share in 2019 is about 20%.
 
North America is the largest consumption place, with a revenue market share nearly 38% in 2019. Following North America, Europe is the second largest consumption place with the revenue market share of about 28% in 2019.
 
This is a minimally invasive surgical method to treat solid cancers, Special probes are used to “burn” or “freeze” cancers without the usual surgery. Computed Tomography (CT), Ultrasound (US) or Magnetic Resonance Imaging (MRI) is used to guide and position the needle probe into the tumor. This requires only a tiny hole, usually less than 3 mm via which the probe is introduced. When the probe is within the cancer it is attached to a generator which “burns” or “freezes” the cancer.
 
The United States average price of Tumor Ablation is in the decreasing trend, from 410 K USD/ Unit in 2011 to 403.6 K USD/Unit in 2015. With the situation of United States economy, prices will be in decreasing trend in the following five years.
 
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Ablation market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Ablation market in terms of revenue.
 
Players, stakeholders, and other participants in the global Tumor Ablation market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
 
Regional and Country-level Analysis
 
The report offers an exhaustive geographical analysis of the global Tumor Ablation market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
 
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
 
Competition Analysis
 
In the competitive analysis section of the report, leading as well as prominent players of the global Tumor Ablation market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
 
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Ablation market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Ablation market.
 
The following players are covered in this report:
  • Angiodynamics
  • Medtronic
  • Boston Scientific
  • Galil Medical
  • Neuwave Medical
  • Misonix
  • Merit Medical
  • Sonacare Medical
  • EDAP TMS
Tumor Ablation Breakdown Data by Type
  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technologies
Tumor Ablation Breakdown Data by Application
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tumor Ablation Revenue
1.4 Market Analysis by Type
1.4.1 Global Tumor Ablation Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Radiofrequency (RF) Ablation
1.4.3 Microwave Ablation
1.4.4 Cryoablation
1.4.5 Other Technologies
1.5 Market by Application
1.5.1 Global Tumor Ablation Market Share by Application: 2020 VS 2026
1.5.2 Liver Cancer
1.5.3 Lung Cancer
1.5.4 Kidney Cancer
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Tumor Ablation Industry Impact
1.6.1 How the Covid-19 is Affecting the Tumor Ablation Industry
1.6.1.1 Tumor Ablation Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Tumor Ablation Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Tumor Ablation Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Tumor Ablation Market Perspective (2015-2026)
2.2 Tumor Ablation Growth Trends by Regions
2.2.1 Tumor Ablation Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Ablation Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Ablation Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tumor Ablation Market Growth Strategy
2.3.6 Primary Interviews with Key Tumor Ablation Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tumor Ablation Players by Market Size
3.1.1 Global Top Tumor Ablation Players by Revenue (2015-2020)
3.1.2 Global Tumor Ablation Revenue Market Share by Players (2015-2020)
3.1.3 Global Tumor Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tumor Ablation Market Concentration Ratio
3.2.1 Global Tumor Ablation Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tumor Ablation Revenue in 2019
3.3 Tumor Ablation Key Players Head office and Area Served
3.4 Key Players Tumor Ablation Product Solution and Service
3.5 Date of Enter into Tumor Ablation Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Tumor Ablation Historic Market Size by Type (2015-2020)
4.2 Global Tumor Ablation Forecasted Market Size by Type (2021-2026)
5 Tumor Ablation Breakdown Data by Application (2015-2026)
5.1 Global Tumor Ablation Market Size by Application (2015-2020)
5.2 Global Tumor Ablation Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tumor Ablation Market Size (2015-2020)
6.2 Tumor Ablation Key Players in North America (2019-2020)
6.3 North America Tumor Ablation Market Size by Type (2015-2020)
6.4 North America Tumor Ablation Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tumor Ablation Market Size (2015-2020)
7.2 Tumor Ablation Key Players in Europe (2019-2020)
7.3 Europe Tumor Ablation Market Size by Type (2015-2020)
7.4 Europe Tumor Ablation Market Size by Application (2015-2020)
8 China
8.1 China Tumor Ablation Market Size (2015-2020)
8.2 Tumor Ablation Key Players in China (2019-2020)
8.3 China Tumor Ablation Market Size by Type (2015-2020)
8.4 China Tumor Ablation Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tumor Ablation Market Size (2015-2020)
9.2 Tumor Ablation Key Players in Japan (2019-2020)
9.3 Japan Tumor Ablation Market Size by Type (2015-2020)
9.4 Japan Tumor Ablation Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tumor Ablation Market Size (2015-2020)
10.2 Tumor Ablation Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tumor Ablation Market Size by Type (2015-2020)
10.4 Southeast Asia Tumor Ablation Market Size by Application (2015-2020)
11 India
11.1 India Tumor Ablation Market Size (2015-2020)
11.2 Tumor Ablation Key Players in India (2019-2020)
11.3 India Tumor Ablation Market Size by Type (2015-2020)
11.4 India Tumor Ablation Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tumor Ablation Market Size (2015-2020)
12.2 Tumor Ablation Key Players in Central & South America (2019-2020)
12.3 Central & South America Tumor Ablation Market Size by Type (2015-2020)
12.4 Central & South America Tumor Ablation Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Angiodynamics
13.1.1 Angiodynamics Company Details
13.1.2 Angiodynamics Business Overview and Its Total Revenue
13.1.3 Angiodynamics Tumor Ablation Introduction
13.1.4 Angiodynamics Revenue in Tumor Ablation Business (2015-2020))
13.1.5 Angiodynamics Recent Development
13.2 Medtronic
13.2.1 Medtronic Company Details
13.2.2 Medtronic Business Overview and Its Total Revenue
13.2.3 Medtronic Tumor Ablation Introduction
13.2.4 Medtronic Revenue in Tumor Ablation Business (2015-2020)
13.2.5 Medtronic Recent Development
13.3 Boston Scientific
13.3.1 Boston Scientific Company Details
13.3.2 Boston Scientific Business Overview and Its Total Revenue
13.3.3 Boston Scientific Tumor Ablation Introduction
13.3.4 Boston Scientific Revenue in Tumor Ablation Business (2015-2020)
13.3.5 Boston Scientific Recent Development
13.4 Galil Medical
13.4.1 Galil Medical Company Details
13.4.2 Galil Medical Business Overview and Its Total Revenue
13.4.3 Galil Medical Tumor Ablation Introduction
13.4.4 Galil Medical Revenue in Tumor Ablation Business (2015-2020)
13.4.5 Galil Medical Recent Development
13.5 Neuwave Medical
13.5.1 Neuwave Medical Company Details
13.5.2 Neuwave Medical Business Overview and Its Total Revenue
13.5.3 Neuwave Medical Tumor Ablation Introduction
13.5.4 Neuwave Medical Revenue in Tumor Ablation Business (2015-2020)
13.5.5 Neuwave Medical Recent Development
13.6 Misonix
13.6.1 Misonix Company Details
13.6.2 Misonix Business Overview and Its Total Revenue
13.6.3 Misonix Tumor Ablation Introduction
13.6.4 Misonix Revenue in Tumor Ablation Business (2015-2020)
13.6.5 Misonix Recent Development
13.7 Merit Medical
13.7.1 Merit Medical Company Details
13.7.2 Merit Medical Business Overview and Its Total Revenue
13.7.3 Merit Medical Tumor Ablation Introduction
13.7.4 Merit Medical Revenue in Tumor Ablation Business (2015-2020)
13.7.5 Merit Medical Recent Development
13.8 Sonacare Medical
13.8.1 Sonacare Medical Company Details
13.8.2 Sonacare Medical Business Overview and Its Total Revenue
13.8.3 Sonacare Medical Tumor Ablation Introduction
13.8.4 Sonacare Medical Revenue in Tumor Ablation Business (2015-2020)
13.8.5 Sonacare Medical Recent Development
13.9 EDAP TMS
13.9.1 EDAP TMS Company Details
13.9.2 EDAP TMS Business Overview and Its Total Revenue
13.9.3 EDAP TMS Tumor Ablation Introduction
13.9.4 EDAP TMS Revenue in Tumor Ablation Business (2015-2020)
13.9.5 EDAP TMS Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
    Table 1. Tumor Ablation Key Market Segments
    Table 2. Key Players Covered: Ranking by Tumor Ablation Revenue
    Table 3. Ranking of Global Top Tumor Ablation Manufacturers by Revenue (US$ Million) in 2019
    Table 4. Global Tumor Ablation Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
    Table 5. Key Players of Radiofrequency (RF) Ablation
    Table 6. Key Players of Microwave Ablation
    Table 7. Key Players of Cryoablation
    Table 8. Key Players of Other Technologies
    Table 9. COVID-19 Impact Global Market: (Four Tumor Ablation Market Size Forecast Scenarios)
    Table 10. Opportunities and Trends for Tumor Ablation Players in the COVID-19 Landscape
    Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
    Table 12. Key Regions/Countries Measures against Covid-19 Impact
    Table 13. Proposal for Tumor Ablation Players to Combat Covid-19 Impact
    Table 14. Global Tumor Ablation Market Size Growth by Application (US$ Million): 2020 VS 2026
    Table 15. Global Tumor Ablation Market Size by Regions (US$ Million): 2020 VS 2026
    Table 16. Global Tumor Ablation Market Size by Regions (2015-2020) (US$ Million)
    Table 17. Global Tumor Ablation Market Share by Regions (2015-2020)
    Table 18. Global Tumor Ablation Forecasted Market Size by Regions (2021-2026) (US$ Million)
    Table 19. Global Tumor Ablation Market Share by Regions (2021-2026)
    Table 20. Market Top Trends
    Table 21. Key Drivers: Impact Analysis
    Table 22. Key Challenges
    Table 23. Tumor Ablation Market Growth Strategy
    Table 24. Main Points Interviewed from Key Tumor Ablation Players
    Table 25. Global Tumor Ablation Revenue by Players (2015-2020) (Million US$)
    Table 26. Global Tumor Ablation Market Share by Players (2015-2020)
    Table 27. Global Top Tumor Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Ablation as of 2019)
    Table 28. Global Tumor Ablation by Players Market Concentration Ratio (CR5 and HHI)
    Table 29. Key Players Headquarters and Area Served
    Table 30. Key Players Tumor Ablation Product Solution and Service
    Table 31. Date of Enter into Tumor Ablation Market
    Table 32. Mergers & Acquisitions, Expansion Plans
    Table 33. Global Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 34. Global Tumor Ablation Market Size Share by Type (2015-2020)
    Table 35. Global Tumor Ablation Revenue Market Share by Type (2021-2026)
    Table 36. Global Tumor Ablation Market Size Share by Application (2015-2020)
    Table 37. Global Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 38. Global Tumor Ablation Market Size Share by Application (2021-2026)
    Table 39. North America Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
    Table 40. North America Key Players Tumor Ablation Market Share (2019-2020)
    Table 41. North America Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 42. North America Tumor Ablation Market Share by Type (2015-2020)
    Table 43. North America Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 44. North America Tumor Ablation Market Share by Application (2015-2020)
    Table 45. Europe Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
    Table 46. Europe Key Players Tumor Ablation Market Share (2019-2020)
    Table 47. Europe Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 48. Europe Tumor Ablation Market Share by Type (2015-2020)
    Table 49. Europe Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 50. Europe Tumor Ablation Market Share by Application (2015-2020)
    Table 51. China Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
    Table 52. China Key Players Tumor Ablation Market Share (2019-2020)
    Table 53. China Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 54. China Tumor Ablation Market Share by Type (2015-2020)
    Table 55. China Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 56. China Tumor Ablation Market Share by Application (2015-2020)
    Table 57. Japan Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
    Table 58. Japan Key Players Tumor Ablation Market Share (2019-2020)
    Table 59. Japan Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 60. Japan Tumor Ablation Market Share by Type (2015-2020)
    Table 61. Japan Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 62. Japan Tumor Ablation Market Share by Application (2015-2020)
    Table 63. Southeast Asia Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
    Table 64. Southeast Asia Key Players Tumor Ablation Market Share (2019-2020)
    Table 65. Southeast Asia Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 66. Southeast Asia Tumor Ablation Market Share by Type (2015-2020)
    Table 67. Southeast Asia Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 68. Southeast Asia Tumor Ablation Market Share by Application (2015-2020)
    Table 69. India Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
    Table 70. India Key Players Tumor Ablation Market Share (2019-2020)
    Table 71. India Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 72. India Tumor Ablation Market Share by Type (2015-2020)
    Table 73. India Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 74. India Tumor Ablation Market Share by Application (2015-2020)
    Table 75. Central & South America Key Players Tumor Ablation Revenue (2019-2020) (Million US$)
    Table 76. Central & South America Key Players Tumor Ablation Market Share (2019-2020)
    Table 77. Central & South America Tumor Ablation Market Size by Type (2015-2020) (Million US$)
    Table 78. Central & South America Tumor Ablation Market Share by Type (2015-2020)
    Table 79. Central & South America Tumor Ablation Market Size by Application (2015-2020) (Million US$)
    Table 80. Central & South America Tumor Ablation Market Share by Application (2015-2020)
    Table 81. Angiodynamics Company Details
    Table 82. Angiodynamics Business Overview
    Table 83. Angiodynamics Product
    Table 84. Angiodynamics Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 85. Angiodynamics Recent Development
    Table 86. Medtronic Company Details
    Table 87. Medtronic Business Overview
    Table 88. Medtronic Product
    Table 89. Medtronic Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 90. Medtronic Recent Development
    Table 91. Boston Scientific Company Details
    Table 92. Boston Scientific Business Overview
    Table 93. Boston Scientific Product
    Table 94. Boston Scientific Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 95. Boston Scientific Recent Development
    Table 96. Galil Medical Company Details
    Table 97. Galil Medical Business Overview
    Table 98. Galil Medical Product
    Table 99. Galil Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 100. Galil Medical Recent Development
    Table 101. Neuwave Medical Company Details
    Table 102. Neuwave Medical Business Overview
    Table 103. Neuwave Medical Product
    Table 104. Neuwave Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 105. Neuwave Medical Recent Development
    Table 106. Misonix Company Details
    Table 107. Misonix Business Overview
    Table 108. Misonix Product
    Table 109. Misonix Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 110. Misonix Recent Development
    Table 111. Merit Medical Company Details
    Table 112. Merit Medical Business Overview
    Table 113. Merit Medical Product
    Table 114. Merit Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 115. Merit Medical Recent Development
    Table 116. Sonacare Medical Business Overview
    Table 117. Sonacare Medical Product
    Table 118. Sonacare Medical Company Details
    Table 119. Sonacare Medical Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 120. Sonacare Medical Recent Development
    Table 121. EDAP TMS Company Details
    Table 122. EDAP TMS Business Overview
    Table 123. EDAP TMS Product
    Table 124. EDAP TMS Revenue in Tumor Ablation Business (2015-2020) (Million US$)
    Table 125. EDAP TMS Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tumor Ablation Market Share by Type: 2020 VS 2026
    Figure 2. Radiofrequency (RF) Ablation Features
    Figure 3. Microwave Ablation Features
    Figure 4. Cryoablation Features
    Figure 5. Other Technologies Features
    Figure 6. Global Tumor Ablation Market Share by Application: 2020 VS 2026
    Figure 7. Liver Cancer Case Studies
    Figure 8. Lung Cancer Case Studies
    Figure 9. Kidney Cancer Case Studies
    Figure 10. Others Case Studies
    Figure 11. Tumor Ablation Report Years Considered
    Figure 12. Global Tumor Ablation Market Size YoY Growth 2015-2026 (US$ Million)
    Figure 13. Global Tumor Ablation Market Share by Regions: 2020 VS 2026
    Figure 14. Global Tumor Ablation Market Share by Regions (2021-2026)
    Figure 15. Porter's Five Forces Analysis
    Figure 16. Global Tumor Ablation Market Share by Players in 2019
    Figure 17. Global Top Tumor Ablation Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Ablation as of 2019
    Figure 18. The Top 10 and 5 Players Market Share by Tumor Ablation Revenue in 2019
    Figure 19. North America Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
    Figure 20. Europe Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
    Figure 21. China Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
    Figure 22. Japan Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
    Figure 23. Southeast Asia Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
    Figure 24. India Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
    Figure 25. Central & South America Tumor Ablation Market Size YoY Growth (2015-2020) (Million US$)
    Figure 26. Angiodynamics Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 27. Angiodynamics Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 28. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 29. Medtronic Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 30. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 31. Boston Scientific Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 32. Galil Medical Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 33. Galil Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 34. Neuwave Medical Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 35. Neuwave Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 36. Misonix Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 37. Misonix Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 38. Merit Medical Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 39. Merit Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 40. Sonacare Medical Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 41. Sonacare Medical Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 42. EDAP TMS Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 43. EDAP TMS Revenue Growth Rate in Tumor Ablation Business (2015-2020)
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Immunotherapy Drugs for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-39R14639
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37I14671
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-33G18542
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-1A14903
Thu Dec 12 00:00:00 UTC 2024

Add to Cart